As uPAR and FPR1 are both involved in tumor progression, an effective cell migration peptide inhibitor (Ac-d-Tyr-d-Arg-AIB-d-Arg-NH) has been synthesized to inhibit the interaction of uPAR and FPR1 to suppress migration and angiogenesis 116, 164. The gene discussed is FPR1; the disease is neoplasm.